Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-267564
Filing Date
2010-11-23
Accepted
2010-11-23 16:07:48
Documents
9
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2010 d10k.htm 10-K 1165199
2 COLLABORATION AGREEMENT dex101.htm EX-10.1 426834
3 CONSENT OF GRANT THORNTON LLP dex231.htm EX-23.1 1734
4 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) / RULE 15D-14(A) dex311.htm EX-31.1 6234
5 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) / RULE 15D-14(A) dex312.htm EX-31.2 6227
6 CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3911
7 CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3912
8 GRAPHIC g120428g16w51.jpg GRAPHIC 32204
9 GRAPHIC g120428g23q40.jpg GRAPHIC 47190
  Complete submission text file 0001193125-10-267564.txt   1725090
Mailing Address 303-A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303-A COLLEGE ROAD EAST PRINCETON NJ 08540 609-613-4100
Pharmasset Inc (Filer) CIK: 0001301081 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-33428 | Film No.: 101211879
SIC: 2834 Pharmaceutical Preparations